DOCTUM PHARMACEUTICAL SA K.GIOKARIS & Co
GR-MF-000015973 · Greece · PEANIA ATTIKIS
DOCTUM PHARMACEUTICAL SA K.GIOKARIS & Co is registered in the European database on medical devices as a manufacturer, with 14 devices declared. It was not found in the U.S. FDA device establishment register.
What this manufacturer declares
| Class IIb | 14 |
|---|
Devices declared under this manufacturer
- BC-2A PLUS /GL1/K+:3/ Ca++:1,5/ Mg++:0,5
- BC-2A PLUS /GL1/K+:3/Ca++:1,75/ Mg++:0,5
- BC-2A PLUS /GL1/K2/Ca1,5/Mg0,5
- BICASOL 650g
- BICASOL CA 650g
- CITRASOL 50% 10L
- CITRASOL 50% 5L
- CITRASOL PLUS 5L
- DOCTICART 650g
- DOCTICART 720g
- DOCTICART 720g (BELLCO)
- DOCTICART CA 650g
Showing 12 of 14 declared devices.
Catalogue references include 04.102171, 04.104006, 04.104054, 04.104070, 04.104072, 04.104073.
European nomenclature codes declared: F040201, F040101, D99.
United States market access
| FDA establishment register | Not found in the FDA register |
|---|---|
| Devices in EUDAMED | 14 |
| Country of registration | Greece |
⚠️ Not found is not the same as not sold — how this comparison can be wrong.
Device-level evidence
| Devices with a numeric GTIN | 14 |
|---|---|
| Found in the U.S. device database | 0 |
| Share | 0.0 % |
Canadian market access
| Health Canada licence listing | Not found in the Canadian register |
|---|
⚠️ Canada lists no Class I devices at all — what that excludes.
North American profile: Neither register. DOCTUM PHARMACEUTICAL SA K.GIOKARIS & Co was not found in either the U.S. or the Canadian register.
Notified body certificates
| Certificate | Status | Expiry |
|---|---|---|
44911221812 | issued | 2031-07-06 |